Visco Vision Inc. (TWSE: 6782)
Health Care · Health Care Equipment & Supplies · TW
NT$230.00
-2.54% today · +16.8% 1Y
Visco Vision Inc. (TWSE: 6782) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $453.17M and employs 16,368 people.
Over the last twelve months the share price has gained 16.8%, trading between 165.50 and 256.00.
Tweenvest scores Visco Vision Inc. across four factors: quality 75/100, value 67/100, growth 98/100, dividend 79/100. Its strongest factor is growth.
6782 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $453.17M
- Revenue (TTM)
- $147.62M
- P/E
- 14.06
- EPS
- 16.36
- Dividend yield
- 3.65%
- Beta (5Y)
- 0.61
- 52-week high
- NT$256.00
- 52-week low
- NT$165.50
- Avg volume (3M)
- —
- Shares outstanding
- 63.00M
- Employees
- 16,368
- Next earnings
- —
About Visco Vision Inc.
Visco Vision, Inc. engages in the production and sale of disposable soft contact lenses, It specializes in design and production of disposable contact lenses with different water content and oxygen permeability According to the same use cycle, it can be divided into daily, weekly, bi-weekly and monthly throws. The company offers general myopia correction, astigmatism, multifocal, anti-blue lens, and makeup lens that can change the color of the iris. Visco Vision was founded on November 9, 1998 and is headquartered in Taoyuan, Taiwan.
- ISIN
- TW0006782006
- Founded
- 1998
- Listed since
- Aug 14, 2020
- Exchange
- Taiwan Stock Exchange
- Currency
- TWD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Chison Medical Technologies Co., Ltd.SHSE: 688358 | $471.90M | CN¥28.19 | -2.63% |
| Cerus CorporationNasdaqGM: CERS | $463.51M | $2.30 | +0.88% |
| BrainsWay Ltd.TASE: BWAY | $463.34M | ₪35.30 | -9.23% |
| Metall Zug AGSWX: METN | $458.63M | CHF859.00 | +0.70% |
| PolyNovo LimitedASX: PNV | $450.76M | AU$0.94 | +1.63% |
| TaiDoc Technology CorporationTWSE: 4736 | $435.69M | NT$134.50 | +2.28% |
| NeuroPace, Inc.NasdaqGM: NPCE | $434.89M | $12.67 | +2.26% |
| Jiangsu Canopus Wisdom Medical Technology Co.,Ltd.SZSE: 301290 | $414.13M | CN¥28.11 | -2.06% |
Figures last refreshed Oct 11, 2026.